Phenothiazines: hope against MDR-TB.

[1]  L. S. Carroll.  Chapter 54 – Antipsychotic Agents and Lithium , 2005 .

[2]  K. Floyd,et al.  Resources Required for Global Tuberculosis Control , 2002, Science.

[3]  L. Amaral,et al.  Activity of phenothiazines against antibiotic-resistant Mycobacterium tuberculosis: a review supporting further studies that may elucidate the potential use of thioridazine as anti-tuberculosis therapy. , 2001, The Journal of antimicrobial chemotherapy.

[4]  L. Amaral,et al.  Enhancement of antibiotic activity against poly-drug resistant Mycobacterium tuberculosis by phenothiazines. , 2001, International journal of antimicrobial agents.

[5]  L. Amaral,et al.  Comparative in vitro activity of phenothiazines against multidrug-resistant Mycobacterium tuberculosis. , 2000, International journal of antimicrobial agents.

[6]  R. Lemmens‐Gruber,et al.  Proarrhythmic effects of antidepressants and neuroleptic drugs on isolated, spontaneously beating guinea-pig Purkinje fibers. , 1999, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[7]  D. Gadre,et al.  Effect of trifluoperazine, a potential drug for tuberculosis with psychotic disorders, on the growth of clinical isolates of drug resistant Mycobactehum tuberculosis , 1998, International clinical psychopharmacology.

[8]  K. Lang,et al.  Life-threatening dysrhythmias in severe thioridazine poisoning treated with physostigmine and transient atrial pacing. , 1997, Critical care medicine.

[9]  L. Amaral,et al.  The potential management of resistant infections with non-antibiotics. , 1997, The Journal of antimicrobial chemotherapy.

[10]  H. Jick,et al.  A Review of Epidemiologic Research on Drug‐Induced Acute Liver Injury Using the General Practice Research Data Base in the United Kingdom , 1997, Pharmacotherapy.

[11]  Lung Disease,et al.  Anti-tuberculosis drug resistance in the world : the WHO/IUATLD Global Project on Anti-tuberculosis Drug Resistance Surveillance , 1997 .

[12]  L. Amaral,et al.  Inhibition of the respiration of multi-drug resistant clinical isolates of Mycobacterium tuberculosis by thioridazine: potential use for initial therapy of freshly diagnosed tuberculosis. , 1996, The Journal of antimicrobial chemotherapy.

[13]  S. Dastidar,et al.  Antimycobacterial activity of methdilazine (Md), an antimicrobic phenothiazine , 1993, APMIS : acta pathologica, microbiologica, et immunologica Scandinavica.

[14]  P. S. Murthy,et al.  Antitubercular activity of trifluoperazine, a calmodulin antagonist. , 1992, FEMS microbiology letters.

[15]  Jaanus Sd,et al.  Ocular side effects of selected systemic drugs. , 1992 .

[16]  A. J. Crowle,et al.  Chlorpromazine: a drug potentially useful for treating mycobacterial infections. , 1992, Chemotherapy.

[17]  T. A. Venkitasubramanian,et al.  Calmodulin-like activity in mycobacteria. , 1991, Indian journal of biochemistry & biophysics.

[18]  M. Marmor.  Is thioridazine retinopathy progressive? Relationship of pigmentary changes to visual function. , 1990, The British journal of ophthalmology.

[19]  Kristiansen Je.  Dyes, antipsychotic drugs, and antimicrobial activity. Fragments of a development, with special reference to the influence of Paul Ehrlich. , 1989 .

[20]  J. Kristiansen,et al.  The antibacterial effect of selected phenothiazines and thioxanthenes on slow-growing mycobacteria. , 2009, Acta pathologica, microbiologica, et immunologica Scandinavica. Section B, Microbiology.

[21]  T. Aw,et al.  Drug-induced hepatotoxicity. , 1986, Annals of internal medicine.

[22]  G. Buettner,et al.  Photoinduced free radicals from chlorpromazine and related phenothiazines: relationship to phenothiazine-induced photosensitization. , 1985, Environmental health perspectives.

[23]  I. Földes,et al.  Studies on antituberculotic action of some phenothiazine derivatives in vitro. , 1977, Zentralblatt fur Bakteriologie, Parasitenkunde, Infektionskrankheiten und Hygiene. Erste Abteilung Originale. Reihe A: Medizinische Mikrobiologie und Parasitologie.

[24]  M. Kamińska.  [Role of chlorpromazine in the treatment of pulmonary tuberculosis in psychiatric patients]. , 1967, Folia medica Cracoviensia.

[25]  P. Guth,et al.  THE PHENOTHIAZINETRANQUILIZERS: BIOCHEMICAL AND BIOPHYSICAL ACTIONS. , 1964, International review of neurobiology.

[26]  J. Bourdon.  [Contribution to the study of the antibiotic properties of chlorpromazine or 4560 RP]. , 1961, Annales de l'Institut Pasteur.

[27]  P. Ehrlich,et al.  Über die Wirkung des Methylenblau bei Malaria , 1960 .

[28]  R. A. Fisher,et al.  Clinical experience with ataractic therapy in tuberculous psychiatric patients. , 1959, Diseases of the chest.

[29]  H. Geiger,et al.  [Largactil in the treatment of tuberculosis]. , 1954, Schweizerische medizinische Wochenschrift.

[30]  H. Geiger,et al.  Largactil (Chlorpromazine) in the Treatment of Tuberculosis. , 1954 .